FRNMFreenome Inc.
−7.3% today · −2.4% over a year
No score: too little data.
Priced higher than most peers. No dividend.
Freenome Inc. (FRNM) belongs to the Health care sector and is listed on Nasdaq; country: United States. Its market value is about €83.1M. Over the past 12 months the price changed by −2.4%, with an annualised volatility of 49% and a largest fall of 39%.
Smart Score
How it is scored →Not scored: not enough data for a fair comparison.
Factor scores
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- Betasupports the score · better than 92% of peers
- Accrualsweighs on the score · better than 12% of peers
- Revenue growth (1 y)weighs on the score · better than 8% of peers
Red flags and notes
- Negative equity Book equity is below zero.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Valuation
- P/S
- 30.2
- Market cap (EUR)
- €83.1M
Dividends
- Dividend yield
- 0.00%
- Years without a lower dividend
- 0
Returns and risk
- 1 day
- −7.3%
- 1 month
- −37.8%
- 1 year
- −2.4%
- Volatility, 1 yr
- 49.4%
- Max drawdown, 1 yr
- −38.8%
- Beta
- 0.56
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
Similar companies
Same sector and region, closest in market value.
| LENZLENZ Therapeutics, Inc. | 1/10 | 0.0% | −86.0% |
|---|---|---|---|
| BDTXBlack Diamond Therapeutics Inc | —/10 | 0.0% | −57.1% |
| VXRTVaxart Inc | —/10 | 0.0% | 12.1% |
| AVXLAnavex Life Sciences Corp. | —/10 | 0.0% | −84.8% |
| ATRAAtara Biotherapeutics Inc | —/10 | 0.0% | −26.0% |
| HCATHealth Catalyst | 1/10 | 0.0% | −50.8% |
| CHRSCoherus Oncology | —/10 | 0.0% | −52.1% |
| ZNTLZentalis Pharmaceuticals | —/10 | 0.0% | 27.6% |
News and filings
- Freenome, Inc.: 8-K — Regulation FD disclosure; other events
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 20 Oct 2026
- Freenome, Inc.: 8-K/A (amendment) — Acquisition or disposition completed
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 13 Aug 2026
What the marks mean
- FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
- Media reportA headline from a named media outlet. We link to it and do not check it.
- RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.
Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
No published ratings in the last 12 months.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.